NDC 62332-506

Azelastine Hydrochloride Ophthalmic Solution 0.05%

Azelastine Hydrochloride Ophthalmic Solution 0.05%

Azelastine Hydrochloride Ophthalmic Solution 0.05% is a Ophthalmic Solution/ Drops in the Human Prescription Drug category. It is labeled and distributed by Alembic Pharmaceuticals Inc.. The primary component is Azelastine Hydrochloride.

Product ID62332-506_104eaae7-b5b9-4a4a-96fc-88bc9ba2bf5c
NDC62332-506
Product TypeHuman Prescription Drug
Proprietary NameAzelastine Hydrochloride Ophthalmic Solution 0.05%
Generic NameAzelastine Hydrochloride Ophthalmic Solution 0.05%
Dosage FormSolution/ Drops
Route of AdministrationOPHTHALMIC
Marketing Start Date2019-03-20
Marketing CategoryANDA / ANDA
Application NumberANDA209620
Labeler NameAlembic Pharmaceuticals Inc.
Substance NameAZELASTINE HYDROCHLORIDE
Active Ingredient Strength1 mg/mL
Pharm ClassesHistamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 62332-506-06

1 BOTTLE in 1 CARTON (62332-506-06) > 6 mL in 1 BOTTLE
Marketing Start Date2019-03-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 62332-506-06 [62332050606]

Azelastine Hydrochloride Ophthalmic Solution 0.05% SOLUTION/ DROPS
Marketing CategoryANDA
Application NumberANDA209620
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2019-03-20

Drug Details

Active Ingredients

IngredientStrength
AZELASTINE HYDROCHLORIDE.5 mg/mL

OpenFDA Data

SPL SET ID:7532ed82-5cfa-49da-83e5-c57ffdd3adbb
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 860805
  • UPC Code
  • 0362332506064
  • Pharmacological Class

    • Histamine H1 Receptor Antagonists [MoA]
    • Histamine-1 Receptor Antagonist [EPC]
    • Histamine H1 Receptor Antagonists [MoA]
    • Histamine-1 Receptor Antagonist [EPC]

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.